Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPN1 | P15169 | 1/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 8/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 8/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | RPLP1 | P05386 | 1/20 | 0.39 |
| ▸ | RPLP0 | P05388 | 1/20 | 0.39 |
| ▸ | RPS17 | P08708 | 1/20 | 0.39 |
| ▸ | RPSA | P08865 | 1/20 | 0.39 |
| ▸ | RPS2 | P15880 | 1/20 | 0.39 |
| ▸ | RPL35A | P18077 | 1/20 | 0.39 |
| ▸ | RPL7 | P18124 | 1/20 | 0.39 |
| ▸ | RPL17 | P18621 | 1/20 | 0.39 |
| ▸ | RPS4Y1 | P22090 | 1/20 | 0.39 |
| ▸ | RPS3 | P23396 | 1/20 | 0.39 |
| ▸ | RPS12 | P25398 | 1/20 | 0.39 |
| ▸ | RPL13 | P26373 | 1/20 | 0.39 |
| ▸ | RPL10 | P27635 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30491023 | 0.85 | SLC6A3 (0.46) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL27132169 | 0.83 | CPN1 (0.41) | CPN1CPB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2788659 | 0.83 | TAS1R3 (0.45) | SLC6A3KMT2A | |
| SCHEMBL27410776 | 0.81 | CPN1 (0.49) | CPN1CPB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL10608107 | 0.81 | OPRL1 (0.43) | KMT2A | |
| SCHEMBL5309381 | 0.81 | SLC6A2 (0.46) | CPN1CPB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL27123836 | 0.78 | CPN1 (0.39) | CPN1CPB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL16475935 | 0.73 | CPN1 (0.47) | CPN1CPB2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31066542 | 0.72 | SLC6A2 (0.47) | SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL18547184 | 0.72 | SLC6A2 (0.47) | SLC6A2SLC6A4SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230416202-A1 | Small Molecule Compounds and Compositions | TELO THERAPEUTICS, INC. | 2023-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230416202-A1 | Small Molecule Compounds and Compositions | TERT, TP53, EP300 | CPN1 3920/4885CPB2 4075/4885SLC6A2 4746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.